BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous carcinoma (LUSC) and lung adenocarcinoma (LUAD) are the common subtypes of NSCLC. However, how LUSC and LUAD are compatible remains to be elucidated.MethodsWe used a network approach to find highly interconnected genes shared with LUSC and LUAD, and we then built modules to assess the degree of preservation between them. To quantify this result, Z-scores were used to summarize the interrelationships between LUSC and LUAD. Furthermore, we correlated network hub genes with patient survival time to identify risk factors.ResultsOur findings provided a look at the regulatory pattern for LUSC and LUAD. For LUSC, several genes, such as AKR1C1, AKR1...
PurposeLung adenocarcinoma (LUAD) is a common type of lung cancer. Cancer in a small number of patie...
PurposeLung adenocarcinoma (LUAD) is a common type of lung cancer. Cancer in a small number of patie...
Lung adenocarcinoma (LUAD) is the most common malignancy, leading to more than 1 million related dea...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
Objective: To explore differentially expressed genes (DEGs) between lung adenocarcinoma (LUAD) and l...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Copyright © 2015 Fei Long et al.This is an open access article distributed under the Creative Common...
Abstract Background Accumulative evidence shows that an organoid is a more practical and reliable to...
Lung cancer is the leading cause of cancer death globally, killing 1.8 million people yearly. Over 8...
PurposeLung adenocarcinoma (LUAD) is a common type of lung cancer. Cancer in a small number of patie...
PurposeLung adenocarcinoma (LUAD) is a common type of lung cancer. Cancer in a small number of patie...
Lung adenocarcinoma (LUAD) is the most common malignancy, leading to more than 1 million related dea...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
BackgroundNon-small cell lung cancer (NSCLC) is a malignant tumor with high mortality. Lung squamous...
Objective: To explore differentially expressed genes (DEGs) between lung adenocarcinoma (LUAD) and l...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogen...
Copyright © 2015 Fei Long et al.This is an open access article distributed under the Creative Common...
Abstract Background Accumulative evidence shows that an organoid is a more practical and reliable to...
Lung cancer is the leading cause of cancer death globally, killing 1.8 million people yearly. Over 8...
PurposeLung adenocarcinoma (LUAD) is a common type of lung cancer. Cancer in a small number of patie...
PurposeLung adenocarcinoma (LUAD) is a common type of lung cancer. Cancer in a small number of patie...
Lung adenocarcinoma (LUAD) is the most common malignancy, leading to more than 1 million related dea...